Amino acid supplements to support brain health in Alzheimer's disease

This trial is testing whether a combination of two amino acids called glycine and N-acetylcysteine (NAC) can help slow cognitive decline and reduce brain inflammation in people with Alzheimer's disease. These amino acids are the building blocks your body uses to make glutathione, a natural protective substance in your brain that appears to be low in Alzheimer's patients. The medication aims to restore glutathione levels and reduce the oxidative stress and inflammation thought to damage brain cells.

Research suggests that low levels of glutathione in the brain contribute to brain damage, inflammation, and cognitive decline in Alzheimer's disease. This trial is testing whether replenishing glutathione with this medication might slow these processes and help preserve memory and thinking skills.